SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-168448
Filing Date
2023-06-16
Accepted
2023-06-16 07:06:00
Documents
16
Period of Report
2023-06-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d523169d8k.htm   iXBRL 8-K 71972
2 EX-2.1 d523169dex21.htm EX-2.1 828334
3 EX-99.1 d523169dex991.htm EX-99.1 52637
7 GRAPHIC g523169g19w31.jpg GRAPHIC 6592
8 GRAPHIC g523169g66d51.jpg GRAPHIC 4455
  Complete submission text file 0001193125-23-168448.txt   1307893

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA chrs-20230615.xsd EX-101.SCH 2850
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE chrs-20230615_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chrs-20230615_pre.xml EX-101.PRE 11261
10 EXTRACTED XBRL INSTANCE DOCUMENT d523169d8k_htm.xml XML 3361
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 231019343
SIC: 2836 Biological Products, (No Diagnostic Substances)